We are pleased to announce that Mirailab Bioscience Inc. (hereinafter referred to as “our company”), has joined as a corporate supporting member of the New National Theatre starting December 2024.
The New National Theatre is Japan’s only national theater that plans, produces, and stages performances in opera, ballet, dance, and drama. The New National Theatre Foundation, a public interest incorporated foundation that operates the New National Theatre, is dedicated to fostering the next generation of talent through its performances. It also conducts outreach programs to provide younger audiences with opportunities to experience outstanding performing arts.
Additionally, the foundation engages in a wide range of activities, including performances at various venues and schools across Japan, video distribution of performances, and support for theatergoers with disabilities, all in pursuit of its mission to contribute to “a spiritually rich and vibrant society with sustainable development.”
Our company deeply resonates with the New National Theatre’s philosophy of striving for artistic excellence, enhancing Japan’s cultural strength, and continuously enriching society. As a corporate supporting member, we have decided to contribute to this meaningful cause.
Guided by our philosophy of “Making Science of Wellness” through NMN research, we are committed not only to academic research but also to actively contributing to social initiatives in the fields of culture and the arts.